Evelyn Partners Investment Management Services Ltd Reduces Stock Position in Agilent Technologies, Inc. $A

Evelyn Partners Investment Management Services Ltd trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 98.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 244 shares of the medical research company’s stock after selling 14,666 shares during the quarter. Evelyn Partners Investment Management Services Ltd’s holdings in Agilent Technologies were worth $28,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of A. Resona Asset Management Co. Ltd. increased its stake in shares of Agilent Technologies by 6.2% in the second quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock worth $11,631,000 after acquiring an additional 5,767 shares during the period. TrueMark Investments LLC purchased a new stake in Agilent Technologies in the second quarter valued at $1,999,000. Fenimore Asset Management Inc grew its position in Agilent Technologies by 2.7% during the 2nd quarter. Fenimore Asset Management Inc now owns 180,880 shares of the medical research company’s stock worth $21,346,000 after purchasing an additional 4,823 shares during the period. Nuance Investments LLC raised its stake in shares of Agilent Technologies by 13.5% during the 2nd quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock valued at $9,523,000 after buying an additional 9,628 shares during the last quarter. Finally, Carmel Capital Partners LLC raised its stake in shares of Agilent Technologies by 32.3% during the 2nd quarter. Carmel Capital Partners LLC now owns 10,928 shares of the medical research company’s stock valued at $1,290,000 after buying an additional 2,667 shares during the last quarter. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the sale, the chief executive officer directly owned 32,058 shares in the company, valued at $4,591,987.92. This represents a 2.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.26% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts have recently commented on A shares. JPMorgan Chase & Co. upped their target price on Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Evercore ISI upped their price objective on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They set a “buy” rating and a $165.00 price objective on the stock. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. Finally, Barclays increased their price target on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a report on Thursday, October 2nd. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $149.62.

Agilent Technologies Price Performance

NYSE:A opened at $151.49 on Friday. The stock has a 50 day moving average of $139.65 and a two-hundred day moving average of $125.24. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The firm has a market cap of $42.95 billion, a P/E ratio of 35.56, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the business posted $1.32 earnings per share. The business’s quarterly revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be issued a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is currently 23.94%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.